Dupixent wins FDA OK for asthma; Seres poaches new CMO from AstraZeneca
→ Sanofi and Regeneron won FDA approval to market Dupixent for asthma. “Dupixent is now approved in the U.S. for two important groups of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
